IRLAB Therapeutics AB Class A's total assets for Q1 2025 were kr159.72M, an increase of 17.26% from the previous quarter. SE:IRLAB.A total liabilities were kr155.09M for the fiscal quarter, a 49.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.